ZP GENERAL PARTNER 1 ApS: Financial statements 2024
CVR: 36402660
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ZP GENERAL PARTNER 1 ApS (CVR 36402660) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 5,000 and a net result of DKK -14,000 compared with DKK -11,000 the year before. That is an increase of 66.7% compared with the year before. The profit margin was -280%. Equity in the 2024 report amounted to DKK 20,000. The solvency ratio was 22.5%.
- Revenue
- DKK 5,000
- Gross Profit
- DKK 5,000
- Profit/Loss
- DKK -14,000
- Equity
- DKK 20,000
- Total Assets
- DKK 89,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 5K | 5K | -14K | 20K | - |
| 2023 | 3K | 3K | -11K | 34K | - |
| 2022 | 3K | 3K | -32K | 45K | - |
| 2021 | 1K USD | 0 USD | -1K USD | 12K USD | - |
| 2020 | 346K USD | 346K USD | 269K USD | 609K USD | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ZP GENERAL PARTNER 1 ApS has published its annual report for 2023. Revenue came to DKK 3,000, and the net result was DKK -11,000.
As of March 21, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ZP GENERAL PARTNER 1 ApS.
As of March 21, 2024, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ZP GENERAL PARTNER 1 ApS.
About ZP GENERAL PARTNER 1 ApS
ZP GENERAL PARTNER 1 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported revenue of DKK 2,000 and a net result of DKK -26,000 compared with DKK -14,000 the year before. Equity in the 2025 report amounted to DKK 81,000.